Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 238 M231 M287 M271 M281 M303 M 1.14 B Research & development —————— — Operating income 370 M439 M635 M650 M411 M574 M 2.27 B Non-Operating Income, Total 1 M3 M-1 M11 M0241 M 251 M Interest expense, net of interest capitalized 6 M8 M8 M10 M8 M10 M 36 M Non-Operating Income, excl. Interest Expenses -6 M-8 M-8 M-10 M-8 M96 M 70 M Unusual income/expense 1 M3 M-1 M11 M0135 M 145 M Pretax income 371 M442 M634 M661 M411 M709 M 2.42 B Equity in earnings —————— — Taxes 35 M56 M78 M56 M65 M136 M 335 M Non-controlling/minority interest 0———-4 M12 M — After tax other income/expense —————— — Net income before discontinued operations 336 M386 M556 M605 M350 M561 M 2.07 B Discontinued operations —————— — Net income 336 M386 M556 M605 M350 M561 M 2.07 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 336 M386 M556 M605 M350 M561 M 2.07 B Basic earnings per share (Basic EPS) 0.380.440.620.680.390.62 2.31 Diluted earnings per share (Diluted EPS) 0.370.420.60.660.380.62 2.26 Average basic shares outstanding 767.15 M767.03 M770.11 M774.11 M788.86 M789 M — Diluted shares outstanding 909.24 M911.01 M918.61 M918.78 M915.04 M913 M — EBITDA 390 M460 M657 M673 M434 M597 M 2.36 B EBIT 370 M439 M635 M650 M411 M574 M 2.27 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 20 M21 M22 M23 M23 M23 M 91 M